Collaboration to provide hospitals with a comprehensive offering across imaging and treatment for cancer patients requiring radiation therapy
Collaboration to accelerate and de-risk clinical development of Nanopharmaceutics CNS portfolio
Bridging the gap between histopathology and molecular pathology
Dr. Hubbard brings more than 35 years of experience in the biopharmaceutical and pharma-tech services industries and CROs.
APAC region contributed around 50% of the in-vitro diagnostics market in 2022
Coordinated by the Medical University of Vienna, a consortium of 13 leading European organizations including university hospitals, research institutions and healthcare companies will conduct the 5-year project co-funded by Horizon Europe.
Philips demonstrates portfolio of smart connected imaging systems and integrated radiology workflow solutions designed to improve diagnostic confidence and clinical outcomes
Athos will perform multi-omic molecular and genetic analyses using biopsies from archived and de-identified Lahey IBD patient samples
TMA will leverage Syntegra's synthetic data engine to accelerate the building of predictive diagnostic algorithms
Healthcare is timely and personal – and its delivery should be too
Subscribe To Our Newsletter & Stay Updated
